ACA

Avoro Capital Advisors Portfolio holdings

AUM $5.71B
1-Year Return 11.37%
This Quarter Return
+42.22%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$2.31B
AUM Growth
+$640M
Cap. Flow
+$54.6M
Cap. Flow %
2.36%
Top 10 Hldgs %
73.05%
Holding
40
New
5
Increased
6
Reduced
12
Closed
6

Top Buys

1
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$52M
2
AMRN
Amarin Corp
AMRN
+$50.3M
3
ARRY
Array Biopharma Inc
ARRY
+$48.8M
4
MDCO
Medicines Co
MDCO
+$43.7M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$35.6M

Top Sells

1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$68.6M
2
LOXO
Loxo Oncology, Inc
LOXO
+$45.5M
3
ASND icon
Ascendis Pharma
ASND
+$21.8M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$21.3M
5
TGTX icon
TG Therapeutics
TGTX
+$19.5M

Sector Composition

1 Healthcare 83.39%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CBAY
26
DELISTED
Cymabay Therapeutics
CBAY
$9.63M 0.42%
+725,000
New +$9.63M
ALIM
27
DELISTED
Alimera Sciences, Inc.
ALIM
$6.61M 0.29%
416,000
– –
TLGT
28
DELISTED
Teligent, Inc
TLGT
$6.07M 0.26%
523,121
-6,879
-1% -$79.8K
FENC icon
29
Fennec Pharmaceuticals
FENC
$253M
$5.36M 0.23%
1,105,999
– –
KOD icon
30
Kodiak Sciences
KOD
$523M
$4.09M 0.18%
627,021
-275,179
-31% -$1.8M
OTLK icon
31
Outlook Therapeutics
OTLK
$51.5M
$630K 0.03%
4,250
– –
NBIX icon
32
Neurocrine Biosciences
NBIX
$14.2B
– –
0
– –
PTCT icon
33
PTC Therapeutics
PTCT
$4.76B
– –
-380,000
Closed -$13M
TGTX icon
34
TG Therapeutics
TGTX
$5.12B
– –
-4,750,000
Closed -$19.5M
XBI icon
35
SPDR S&P Biotech ETF
XBI
$5.47B
– –
0
– –
YMAB icon
36
Y-mAbs Therapeutics
YMAB
$390M
– –
-310,000
Closed -$6.31M
KA
37
DELISTED
Kineta, Inc. Common Stock
KA
– –
-9,286
Closed -$4.21M
ACER
38
DELISTED
Acer Therapeutics Inc. Common Stock (DE)
ACER
– –
-150,000
Closed -$3.02M
LOXO
39
DELISTED
Loxo Oncology, Inc
LOXO
– –
-325,000
Closed -$45.5M
1
2